Overexpression of checkpoint proteins have previously been linked to Lynch syndrome and abrogation of the checkpoint machinery has been shown to sensitize MMR deficient tumor cells towards chemotherapy [39], [40]. This evidence concerns the gene MRC1 and neoplasm.